FIELD: medicine; pharmacology.
SUBSTANCE: kauran compounds are used for production of pharmaceutical preparations prescribed for the patients suffering from ischemic disease of tissues and organs. Herewith kauran compounds are compound A presented in the Formula 2 
(isosteviol) and compound B, presented in formula 3 
(steviol).
EFFECT: higher efficiency and safety in comparison with methods and medicines nowadays used for treatment of tissue and organ ischemia.
15 cl, 12 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| USE OF TALIPORFIN OR ITS DERIVATIVES IN TREATMENT OF HEART DISEASES, AND ALSO THEIR DERIVATION | 2001 |
|
RU2350326C2 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| METHOD OF DIABETES TREATMENT | 2007 |
|
RU2442585C2 |
| USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2013 |
|
RU2672341C2 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
| PEPTIDE COMPOUND RECOVERING FUNCTION OF MYOCARDIUM | 2004 |
|
RU2255756C1 |
| METHOD OF MYOCARDIUM INFARCTION TREATMENT | 2003 |
|
RU2330665C2 |
